The World Health Organization is officially backing popular weight-loss drugs like Ozempic and Wegovy. The WHO published new guidelines about glucagon-like peptide-1 (GLP-1) medications in the medical ...

Add Yahoo as a preferred source to see more of our stories on Google. In a move that could reshape how doctors approach both weight and heart health, the American College of Cardiology (ACC) released ...

The WHO recommended GLP-1s as a treatment for obesity alongside a healthy diet and regular exercise. Milles Team/Stocksy The World Health Organization (WHO) has recommended the use of GLP-1 ...

GLP-1 receptor agonists for obesity are effective over the long term when paired with lifestyle interventions, but global accessibility must be improved, the World Health Organization (WHO) concluded.

A new World Health Organization (WHO) guideline recommending GLP-1s for obesity treatment along with recent efforts to reduce the drugs’ costs are unlikely to change US obesity practice — but actions ...

Preoperative GLP-1 therapy may reduce surgical risks in obese patients without increasing perioperative complications, offering a scalable weight management strategy. Updated ASA guidelines recommend ...

American Academy of Pediatrics guidelines that set off a new era in obesity treatment — and a national debate about whether children should be prescribed weight loss drugs — may have been shaped by ...

GLP-1 drugs now have new guidelines The World Health Organization has laid down its first guidelines for GLP-1 drugs like Wegovy and Zepbound.

Plus, expert-backed tips for protecting your bones.

At this year's American Society of Regional Anesthesia and Pain Medicine (ASRA) annual meeting, researchers at Hospital for Special Surgery (HSS) presented two studies focused on glucagon-like peptide ...

The World Health Organization (WHO) has recommended the use of GLP-1 medications as part of treatment programs to help people manage obesity. In a new guideline published in JAMA, WHO officials said ...